|
Delayed
Australian S.E.
05:43:42 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 196.12 AUD | -0.09% |
|
+6.28% | +13.63% |
| 10-20 | BHP and National Australia Bank drag Aussie shares lower | RE |
| 10-14 | EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing -- Update | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.82B | |||||
| 1,144B | |||||
| 625B | |||||
| 511B | |||||
| 377B | |||||
| 366B |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
